127 related articles for article (PubMed ID: 6517552)
1. Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.
Bansal MB; Chuah SK; Thadepalli H
Antimicrob Agents Chemother; 1984 Oct; 26(4):606-7. PubMed ID: 6517552
[TBL] [Abstract][Full Text] [Related]
2. The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
Simpson CN; Maskell JP; Williams JD
J Antimicrob Chemother; 1984 Aug; 14(2):133-8. PubMed ID: 6334069
[TBL] [Abstract][Full Text] [Related]
3. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.
Fekete T; McGowen J; Cundy KR
Antimicrob Agents Chemother; 1987 Feb; 31(2):321-2. PubMed ID: 3032097
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
Bansal MB; Chuah SK; Thadepalli H
Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
[TBL] [Abstract][Full Text] [Related]
7. Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis.
Indiveri MC; Hirsh DC
Am J Vet Res; 1985 Oct; 46(10):2207-9. PubMed ID: 4062030
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
9. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
Lamothe F; Auger F; Lacroix JM
Antimicrob Agents Chemother; 1984 May; 25(5):662-5. PubMed ID: 6732233
[TBL] [Abstract][Full Text] [Related]
10. Lack of standardization of in-vitro susceptibility testing of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1991 Jul; 28(1):147-9. PubMed ID: 1769936
[No Abstract] [Full Text] [Related]
11. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
[TBL] [Abstract][Full Text] [Related]
13. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
de Barbeyrac B; Quentin C; Bebear C
Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
16. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Maskell JP; Nasu M; Williams JD
J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Aldridge KE
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
[TBL] [Abstract][Full Text] [Related]
20. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
